Cargando…

Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays

The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with man...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dong, Gebreab, Yacob Berhane, Hu, Jian, Zhou, Lili, Zhang, Ning, Tong, Hui, Chen, Bin, Wang, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324022/
https://www.ncbi.nlm.nih.gov/pubmed/35885633
http://dx.doi.org/10.3390/diagnostics12071729
_version_ 1784756705143291904
author Liu, Dong
Gebreab, Yacob Berhane
Hu, Jian
Zhou, Lili
Zhang, Ning
Tong, Hui
Chen, Bin
Wang, Xiaoqin
author_facet Liu, Dong
Gebreab, Yacob Berhane
Hu, Jian
Zhou, Lili
Zhang, Ning
Tong, Hui
Chen, Bin
Wang, Xiaoqin
author_sort Liu, Dong
collection PubMed
description The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with many detection platforms, these remain insufficient. Additionally, there is a need for more methods that can achieve fully automated anti-biotin interference. We sought to develop and evaluate a new biotin interference-resisting method based on a biotin-streptavidin chemiluminescence immunoassay. Streptavidin-coated magnetic microparticles (M) of different concentrations were prepared and tested for their biotin-resistance capabilities in an automated setting (Cobas e 601). The precision, accuracy, and detection capability were also assessed. Higher concentrations of M were found to have a stronger ability to resist biotin interference. A 2.16 mg/mL concentration of M was able to resist 500 ng/mL of biotin in samples while simultaneously having a relatively weak shielding effect on the optical signals. Moreover, the total precision and accuracy of this method, designated as M3, met acceptable standards. M3 has an improved ability to resist biotin interference, can achieve full automation, and its detection performance can meet the general laboratory quality requirements.
format Online
Article
Text
id pubmed-9324022
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93240222022-07-27 Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays Liu, Dong Gebreab, Yacob Berhane Hu, Jian Zhou, Lili Zhang, Ning Tong, Hui Chen, Bin Wang, Xiaoqin Diagnostics (Basel) Article The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with many detection platforms, these remain insufficient. Additionally, there is a need for more methods that can achieve fully automated anti-biotin interference. We sought to develop and evaluate a new biotin interference-resisting method based on a biotin-streptavidin chemiluminescence immunoassay. Streptavidin-coated magnetic microparticles (M) of different concentrations were prepared and tested for their biotin-resistance capabilities in an automated setting (Cobas e 601). The precision, accuracy, and detection capability were also assessed. Higher concentrations of M were found to have a stronger ability to resist biotin interference. A 2.16 mg/mL concentration of M was able to resist 500 ng/mL of biotin in samples while simultaneously having a relatively weak shielding effect on the optical signals. Moreover, the total precision and accuracy of this method, designated as M3, met acceptable standards. M3 has an improved ability to resist biotin interference, can achieve full automation, and its detection performance can meet the general laboratory quality requirements. MDPI 2022-07-16 /pmc/articles/PMC9324022/ /pubmed/35885633 http://dx.doi.org/10.3390/diagnostics12071729 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Dong
Gebreab, Yacob Berhane
Hu, Jian
Zhou, Lili
Zhang, Ning
Tong, Hui
Chen, Bin
Wang, Xiaoqin
Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title_full Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title_fullStr Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title_full_unstemmed Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title_short Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
title_sort development and evaluation of an anti-biotin interference method in biotin-streptavidin immunoassays
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324022/
https://www.ncbi.nlm.nih.gov/pubmed/35885633
http://dx.doi.org/10.3390/diagnostics12071729
work_keys_str_mv AT liudong developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT gebreabyacobberhane developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT hujian developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT zhoulili developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT zhangning developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT tonghui developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT chenbin developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays
AT wangxiaoqin developmentandevaluationofanantibiotininterferencemethodinbiotinstreptavidinimmunoassays